About Apionex
Apionex is a Healthcare company based in Mumbai (India). Manufacturing of active pharmaceutical ingredients and contract-based molecule development services. Its Indian entity Apionex Pharma Private Limited reported revenue of ₹17.29 Cr. Apionex offers products and services including Hydroquinone and Triclofos Sodium. Its focus areas include R&D Services, Drug Development, Contract Manufacturing and Pharmaceuticals.
Company details
Apionex is engaged in the manufacturing and supplying of active pharmaceutical ingredients, with development of new molecules undertaken on a contract basis. A focus is placed on delivering value-added services cost-effectively, adhering to regulatory standards and emphasizing innovation and quality. The company is recognized for its RD efforts using advanced technologies, ensuring compliance and building partnerships globally. Products such as Hydroquinone and Triclofos Sodium are produced to meet medical needs, while ethical practices are maintained in operations.
- Headquarters Mumbai, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website apionex.com
- Legal Name Apionex Pharma Pvt Ltd
- Date of Incorporation 05 Oct, 2018
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹17.29 Cr
FY 2024 · +5% YoY
- Net Profit₹65.5 Lakh
FY 2024 · 4% margin
- EBITDA₹97.3 Lakh
FY 2024 · 6% margin
Associated legal entities of Apionex
Apionex operates through Apionex Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Apionex Pharma Private Limited CIN U33209MH2018PTC315329 | Active | 05 Oct 2018 | Mumbai, Maharashtra | ₹17.3 Cr | 3 | View details |
Products & Services of Apionex
Apionex offers a comprehensive portfolio of products and services, including Hydroquinone and Triclofos Sodium.
Hydroquinone is used as a depigmentation agent in pharmaceutical applications.
Triclofos Sodium is utilized for treating insomnia as a sedative drug in medical contexts.
Board of directors of Apionex Pharma Private Limited (Apionex)
Apionex Pharma Private Limited is the primary company behind Apionex. The board of Apionex Pharma Private Limited currently have 3 directors; the longest-serving is Nirav Vinod Shah, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nirav Vinod Shah DIN 07988688 | Director | 05 Oct 2018 | 8 yrs 1 mo | Apionex Pharma Private Limited |
| Nikita Nirav Shah DIN 10862335 | Director appointed in casual vacancy | 09 Dec 2024 | 1 yr 10 mo | Apionex Pharma Private Limited |
| Chintal Tejas Laliwala DIN 10862180 | Additional Director | 11 Dec 2024 | 1 yr 10 mo | Apionex Pharma Private Limited |
Financials of Apionex
Figures of Apionex Pharma Private Limited, the primary company behind Apionex, for FY 2024. Revenue was ₹17.29 Cr (+5% year on year). Net profit was ₹65.5 Lakh (4% margin). EBITDA was ₹97.3 Lakh (6% margin). Revenue has grown at a compounded annual rate of +31% over three years and +236% over five years.
- ₹17.29 CrRevenue · FY 2024 · +5% YoY
- ₹65.5 LakhNet profit · 4% margin
- ₹97.3 LakhEBITDA · 6% margin
- ₹10 LakhPaid-up capital
- +31%Revenue CAGR, 3 years
- +236%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Apionex Pharma Private Limited are on its company page.
Detailed financial statements for Apionex
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Apionex
Apionex is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Apionex, Apionex Pharma Private Limited, reported revenue of ₹17.29 Cr for FY 2024, up 5% year on year.
Apionex is engaged in the manufacturing and supplying of active pharmaceutical ingredients, with development of new molecules undertaken on a contract basis. A focus is placed on delivering value-added services cost-effectively, adhering to regulatory standards and emphasizing innovation and quality. The company is recognized for its RD efforts using advanced technologies, ensuring compliance and building partnerships globally. Products such as Hydroquinone and Triclofos Sodium are produced to meet medical needs, while ethical practices are maintained in operations.
Apionex offers Hydroquinone and Triclofos Sodium.
Apionex operates through Apionex Pharma Private Limited.
The legal entities of Apionex currently have 3 directors, including Nirav Vinod Shah, Nikita Nirav Shah, Chintal Tejas Laliwala.